Pediatrix Medical Group, Inc. (NYSE:MD) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 7.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 256,335 shares of the company's stock after acquiring an additional 18,627 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.30% of Pediatrix Medical Group worth $3,363,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Nomura Asset Management Co. Ltd. boosted its stake in shares of Pediatrix Medical Group by 95.3% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after acquiring an additional 1,220 shares in the last quarter. Parkside Financial Bank & Trust raised its holdings in Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares during the period. AlphaQuest LLC raised its holdings in Pediatrix Medical Group by 65.9% in the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares during the period. Smartleaf Asset Management LLC boosted its position in Pediatrix Medical Group by 750.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after purchasing an additional 6,090 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock worth $98,000 after purchasing an additional 5,104 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company's stock.

Analysts Set New Price Targets

MD has been the subject of a number of recent analyst reports. UBS Group cut their price objective on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research report on Monday, May 12th. Macquarie boosted their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Finally, Truist Financial reduced their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group currently has an average rating of "Hold" and a consensus target price of $16.67.

Pediatrix Medical Group Price Performance

Shares of NYSE MD traded up $0.19 during midday trading on Friday, hitting $14.11. The stock had a trading volume of 771,894 shares, compared to its average volume of 826,578. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The stock has a 50 day simple moving average of $13.65 and a 200-day simple moving average of $14.00. The company has a market capitalization of $1.21 billion, a PE ratio of -11.76, a P/E/G ratio of 1.74 and a beta of 1.27. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The firm had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. During the same period in the prior year, the company earned $0.20 EPS. The firm's revenue was down 7.4% compared to the same quarter last year. On average, sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.